Gopherus evgoodei ecotype Sinaloan lineage chromosome 14, rGopEvg1_v1.p, whole genome shotgun sequence.
Gopherus evgoodei (Goodes thornscrub tortoise)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Testudinidae; Gopherus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM017309.1.\nAssembly name: rGopEvg1_v1.p\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2019/07/25. The original whole-genome shotgun project has the\naccession VHHN00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 31-JAN-2019\nAssembly Method :: FALCON v. 5.1.1; FALCON-Unzip v. 1.0.2;\n purge_haplotigs v. bitbucket 7.10.2018;\n scaff10x v. 2.1; Bionano Solve DLS v.\n 3.2.1; Salsa2 v. 2.2; Arrow v.\n 5.1.0.26412; longranger align v. 2.2.2;\n freebayes v. 1.2.0; gEVAL manual curation\n v. 2019-01-31; VGP standard assembly\n pipeline v. 1.5\nAssembly Name :: rGopEvg1_v1.p\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 58.0x\nSequencing Technology :: PacBio Sequel I; 10X Genomics linked\n reads; Arima Genomics Hi-C; Bionano\n Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Gopherus evgoodei Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.2\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
protein-glutamine gamma-glutamyltransferase E-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
protein-glutamine gamma-glutamyltransferase 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger NFX1-type containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger NFX1-type containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger NFX1-type containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger NFX1-type containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger NFX1-type containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger NFX1-type containing 1, transcript variant X4
NFX1-type zinc finger-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX27
small nuclear ribonucleoprotein polypeptides B and B1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
small nuclear ribonucleoprotein-associated proteins B and B'
engulfment and cell motility 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
engulfment and cell motility 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X2
engulfment and cell motility 2, transcript variant X4
engulfment and cell motility protein 2 isoform X1
engulfment and cell motility protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
engulfment and cell motility 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
engulfment and cell motility protein 2 isoform X3
engulfment and cell motility 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
engulfment and cell motility protein 2 isoform X4
solute carrier family 35 member C2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 35 member C2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 35 member C2 isoform X2
solute carrier family 35 member C2 isoform X3
solute carrier family 35 member C2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 35 member C2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 35 member C2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 35 member C2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 35 member C2, transcript variant X3
solute carrier family 35 member C2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 35 member C2 isoform X1
solute carrier family 35 member C2 isoform X5
solute carrier family 35 member C2, transcript variant X9
solute carrier family 35 member C2 isoform X4
solute carrier family 35 member C2 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 5 isoform X2
nuclear receptor coactivator 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nuclear receptor coactivator 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
nuclear receptor coactivator 5 isoform X2
nuclear receptor coactivator 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative uncharacterized protein C18orf15
solute carrier family 12 member 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 12 member 5-like, transcript variant X2
solute carrier family 12 member 5-like isoform X1
solute carrier family 12 member 5-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger protein 335, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger protein 335, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 335, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 335, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 335, transcript variant X6
zinc finger protein 335, transcript variant X7
zinc finger protein 335, transcript variant X3
zinc finger protein 335, transcript variant X4
zinc finger protein 335, transcript variant X5
ankyrin repeat domain-containing protein SOWAHC-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase RNF182-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF182-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase RNF182-like, transcript variant X3
E3 ubiquitin-protein ligase RNF182-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: phospholipid transfer protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 6 bases in 5 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 6 bases in 5 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: lysosomal protective protein
neuralized E3 ubiquitin protein ligase 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: neuralized-like protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger SWIM domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger SWIM domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulator of G-protein signaling 9-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 C, transcript variant X2
ubiquitin-conjugating enzyme E2 C isoform X1
ubiquitin-conjugating enzyme E2 C isoform X2
deoxynucleotidyltransferase terminal interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
deoxynucleotidyltransferase terminal interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
deoxynucleotidyltransferase terminal interacting protein 1, transcript variant X2
deoxynucleotidyltransferase terminal-interacting protein 1 isoform X1
deoxynucleotidyltransferase terminal-interacting protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
WAP four-disulfide core domain protein 3
serine peptidase inhibitor, Kunitz type 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
WAP four-disulfide core domain protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WAP four-disulfide core domain protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
kunitz-type serine protease inhibitor B1-like, transcript variant X2
kunitz-type serine protease inhibitor B1-like, transcript variant X1
kunitz-type serine protease inhibitor B1-like isoform X2
BPTI/Kunitz domain-containing protein-like isoform X1
WAP four-disulfide core domain protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WAP four-disulfide core domain protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WAP four-disulfide core domain protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
WAP four-disulfide core domain protein 8-like isoform X1
WAP four-disulfide core domain protein 3-like isoform X3
WAP four-disulfide core domain protein 8-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
V-set and transmembrane domain containing 2 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
V-set and transmembrane domain containing 2 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
V-set and transmembrane domain-containing protein 2-like protein isoform X1
V-set and transmembrane domain-containing protein 2-like protein isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: TELO2-interacting protein 1 homolog
regulation of nuclear pre-mRNA domain containing 1B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: regulation of nuclear pre-mRNA domain-containing protein 1B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein-glutamine gamma-glutamyltransferase 2
KIAA1755 ortholog, transcript variant X2
KIAA1755 ortholog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein KIAA1755 homolog isoform X2
uncharacterized protein KIAA1755 homolog isoform X1
bactericidal permeability increasing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
bactericidal permeability-increasing protein
CDK5 regulatory subunit associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CDK5 regulatory subunit-associated protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
BPI fold-containing family B member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
WD repeat-containing protein on Y chromosome-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
EF-hand calcium-binding domain-containing protein 8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
microtubule associated protein RP/EB family member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
microtubule associated protein RP/EB family member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
microtubule-associated protein RP/EB family member 1
DNA methyltransferase 3 beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA methyltransferase 3 beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA methyltransferase 3 beta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA methyltransferase 3 beta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA methyltransferase 3 beta, transcript variant X1
DNA (cytosine-5)-methyltransferase 3B isoform X4
DNA (cytosine-5)-methyltransferase 3B isoform X3
DNA (cytosine-5)-methyltransferase 3B isoform X1
DNA (cytosine-5)-methyltransferase 3B isoform X2
DNA methyltransferase 3 beta, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA (cytosine-5)-methyltransferase 3B isoform X5
DNA methyltransferase 3 beta, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA (cytosine-5)-methyltransferase 3B isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein O-fucosyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein O-fucosyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
GDP-fucose protein O-fucosyltransferase 1 isoform X1
GDP-fucose protein O-fucosyltransferase 1 isoform X2
PLAG1 like zinc finger 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PLAG1 like zinc finger 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PLAG1 like zinc finger 2, transcript variant X3
transmembrane 9 superfamily member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane 9 superfamily member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transmembrane 9 superfamily member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane 9 superfamily member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane 9 superfamily member 4 isoform X3
transmembrane 9 superfamily member 4 isoform X1
transmembrane 9 superfamily member 4 isoform X2
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
HCK proto-oncogene, Src family tyrosine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CCM2 like scaffold protein, transcript variant X2
CCM2 like scaffold protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cerebral cavernous malformations 2 protein-like isoform X2
cerebral cavernous malformations 2 protein-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
tubulin tyrosine ligase like 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tubulin tyrosine ligase like 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable tubulin polyglutamylase TTLL9 isoform X2
probable tubulin polyglutamylase TTLL9 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
interferon regulatory factor 4-like, transcript variant X2
interferon regulatory factor 4-like, transcript variant X1
interferon regulatory factor 4-like isoform X2
interferon regulatory factor 4-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
myosin light chain kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
myosin light chain kinase 2, transcript variant X1
myosin light chain kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
myosin light chain kinase 2, skeletal/cardiac muscle isoform X3
myosin light chain kinase 2, skeletal/cardiac muscle isoform X1
myosin light chain kinase 2, skeletal/cardiac muscle isoform X2
TPX2 microtubule nucleation factor, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TPX2 microtubule nucleation factor, transcript variant X5
TPX2 microtubule nucleation factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TPX2 microtubule nucleation factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TPX2 microtubule nucleation factor, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TPX2 microtubule nucleation factor, transcript variant X4
TPX2 microtubule nucleation factor, transcript variant X2
TPX2 microtubule nucleation factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cytochrome c oxidase subunit 4 isoform 1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
bactericidal permeability-increasing protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
inhibitor of DNA binding 1, HLH protein, transcript variant X2
inhibitor of DNA binding 1, HLH protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA-binding protein inhibitor ID-1 isoform X2
DNA-binding protein inhibitor ID-1 isoform X1
histocompatibility minor 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
histocompatibility minor 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
minor histocompatibility antigen H13 isoform X2
minor histocompatibility antigen H13 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome 14 C20orf96 homolog, transcript variant X4
chromosome 14 C20orf96 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome 14 C20orf96 homolog, transcript variant X2
chromosome 14 C20orf96 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromosome 14 C20orf96 homolog, transcript variant X3
uncharacterized protein C20orf96 homolog isoform X1
uncharacterized protein C20orf96 homolog isoform X3
uncharacterized protein C20orf96 homolog isoform X4
uncharacterized protein C20orf96 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RANBP2-type and C3HC4-type zinc finger containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RANBP2-type and C3HC4-type zinc finger containing 1, transcript variant X1
RANBP2-type and C3HC4-type zinc finger containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RANBP2-type and C3HC4-type zinc finger containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
RANBP2-type and C3HC4-type zinc finger containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ranBP-type and C3HC4-type zinc finger-containing protein 1 isoform X2
ranBP-type and C3HC4-type zinc finger-containing protein 1 isoform X1
ranBP-type and C3HC4-type zinc finger-containing protein 1 isoform X5
ranBP-type and C3HC4-type zinc finger-containing protein 1 isoform X3
RANBP2-type and C3HC4-type zinc finger containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ranBP-type and C3HC4-type zinc finger-containing protein 1 isoform X4
TBC1 domain family member 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
TBC1 domain family member 20, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TBC1 domain family member 20, transcript variant X3
TBC1 domain family member 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
casein kinase 2 alpha 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
casein kinase 2 alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
scratch family transcriptional repressor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 52, riboflavin transporter, member 3
family with sequence similarity 110 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 53% coverage of the annotated genomic feature by RNAseq alignments
double-strand-break repair protein rad21-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
syndecan binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
syndecan binding protein 2, transcript variant X1
syndecan binding protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
syndecan binding protein 2, transcript variant X3
syndecan binding protein 2, transcript variant X5
FKBP prolyl isomerase 1A, transcript variant X2
peptidyl-prolyl cis-trans isomerase FKBP1A isoform X2
FKBP prolyl isomerase 1A, transcript variant X1
FKBP prolyl isomerase 1A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
FKBP prolyl isomerase 1A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
FKBP prolyl isomerase 1A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
FKBP prolyl isomerase 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP1A isoform X4
peptidyl-prolyl cis-trans isomerase FKBP1A isoform X1
peptidyl-prolyl cis-trans isomerase FKBP1A isoform X3
peptidyl-prolyl cis-trans isomerase FKBP1A isoform X5
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X3
sodium-dependent lysophosphatidylcholine symporter 1-like isoform X6
sodium-dependent lysophosphatidylcholine symporter 1-like isoform X3
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC115634983 isoform X2
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X1
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X4
uncharacterized protein LOC115634983 isoform X5
uncharacterized protein LOC115634983 isoform X1
uncharacterized protein LOC115634983 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 67% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type substrate 1-like isoform X2
tyrosine-protein phosphatase non-receptor type substrate 1-like isoform X3
tyrosine-protein phosphatase non-receptor type substrate 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type substrate 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
fibronectin type III domain containing 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibronectin type III domain-containing protein 11
helicase with zinc finger 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
helicase with zinc finger 2, transcript variant X1
helicase with zinc finger 2, transcript variant X4
helicase with zinc finger domain 2 isoform X2
helicase with zinc finger domain 2 isoform X1
helicase with zinc finger domain 2 isoform X4
helicase with zinc finger 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
helicase with zinc finger domain 2 isoform X3
glucocorticoid modulatory element binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glucocorticoid modulatory element binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
glucocorticoid modulatory element-binding protein 2 isoform X1
glucocorticoid modulatory element-binding protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
regulator of telomere elongation helicase 1, transcript variant X3
regulator of telomere elongation helicase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
regulator of telomere elongation helicase 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
regulator of telomere elongation helicase 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
regulator of telomere elongation helicase 1, transcript variant X7
regulator of telomere elongation helicase 1, transcript variant X10
regulator of telomere elongation helicase 1, transcript variant X8
regulator of telomere elongation helicase 1, transcript variant X4
regulator of telomere elongation helicase 1, transcript variant X5
regulator of telomere elongation helicase 1, transcript variant X11
regulator of telomere elongation helicase 1, transcript variant X2
regulator of telomere elongation helicase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of telomere elongation helicase 1 isoform X1
regulator of telomere elongation helicase 1 isoform X4
regulator of telomere elongation helicase 1 isoform X7
regulator of telomere elongation helicase 1 isoform X5
regulator of telomere elongation helicase 1 isoform X2
regulator of telomere elongation helicase 1 isoform X6
regulator of telomere elongation helicase 1 isoform X10
regulator of telomere elongation helicase 1 isoform X8
regulator of telomere elongation helicase 1 isoform X3
regulator of telomere elongation helicase 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
regulator of telomere elongation helicase 1 isoform X9
TNF receptor superfamily member 6b, transcript variant X3
TNF receptor superfamily member 6b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TNF receptor superfamily member 6b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TNF receptor superfamily member 6b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
TNF receptor superfamily member 6b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 6B isoform X3
tumor necrosis factor receptor superfamily member 6B isoform X2
tumor necrosis factor receptor superfamily member 6B isoform X1
ADP ribosylation factor related protein 1, transcript variant X3
ADP ribosylation factor related protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ADP-ribosylation factor-related protein 1 isoform X1
ADP-ribosylation factor-related protein 1 isoform X3
ADP ribosylation factor related protein 1, transcript variant X2
ADP-ribosylation factor-related protein 1 isoform X2
ADP ribosylation factor related protein 1, transcript variant X4
ADP-ribosylation factor-related protein 1 isoform X4
zinc finger CCCH-type and G-patch domain containing
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger CCCH-type with G patch domain-containing protein
Lck interacting transmembrane adaptor 1, transcript variant X2
Lck interacting transmembrane adaptor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Lck interacting transmembrane adaptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger and BTB domain containing 46, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 46 isoform X2
zinc finger and BTB domain containing 46, transcript variant X2
zinc finger and BTB domain containing 46, transcript variant X3
zinc finger and BTB domain containing 46, transcript variant X6
zinc finger and BTB domain containing 46, transcript variant X8
zinc finger and BTB domain containing 46, transcript variant X7
zinc finger and BTB domain containing 46, transcript variant X4
zinc finger and BTB domain containing 46, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger and BTB domain containing 46, transcript variant X5
zinc finger and BTB domain-containing protein 46 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tripartite motif-containing protein 55-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DnaJ heat shock protein family (Hsp40) member C5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
DnaJ heat shock protein family (Hsp40) member C5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uridine-cytidine kinase 1 like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uridine-cytidine kinase 1 like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uridine-cytidine kinase 1 like 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uridine-cytidine kinase 1 like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uridine-cytidine kinase 1 like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uridine-cytidine kinase 1 like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uridine-cytidine kinase 1 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uridine-cytidine kinase-like 1 isoform X3
uridine-cytidine kinase-like 1 isoform X4
uridine-cytidine kinase-like 1 isoform X5
uridine-cytidine kinase-like 1 isoform X1
uridine-cytidine kinase-like 1 isoform X2
zinc finger protein 512B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X2
zinc finger protein 512B, transcript variant X4
zinc finger protein 512B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sterile alpha motif domain containing 10
sterile alpha motif domain-containing protein 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromosome 14 C20orf204 homolog, transcript variant X2
uncharacterized protein C20orf204 homolog isoform X2
chromosome 14 C20orf204 homolog, transcript variant X1
uncharacterized protein C20orf204 homolog isoform X1
transcription elongation factor A2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription elongation factor A2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transcription elongation factor A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transcription elongation factor A protein 2 isoform X2
transcription elongation factor A protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LKAAEAR motif containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LKAAEAR motif containing 1, transcript variant X3
LKAAEAR motif containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: myelin transcription factor 1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X12
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X8
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X3
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X10
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X11
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2, transcript variant X5
protein-L-isoaspartate O-methyltransferase domain-containing protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: peroxidasin homolog
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
pancreatic progenitor cell differentiation and proliferation factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
eukaryotic translation elongation factor 1 alpha 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
eukaryotic translation elongation factor 1 alpha 2, transcript variant X2
potassium voltage-gated channel subfamily Q member 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: potassium voltage-gated channel subfamily KQT member 2
cholinergic receptor nicotinic alpha 4 subunit
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: neuronal acetylcholine receptor subunit alpha-4
collagen type XX alpha 1 chain, transcript variant X3
collagen type XX alpha 1 chain, transcript variant X1
collagen type XX alpha 1 chain, transcript variant X2
DEP domain-containing mTOR-interacting protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DEP domain-containing mTOR-interacting protein-like, transcript variant X1
DEP domain-containing mTOR-interacting protein-like isoform X2
DEP domain-containing mTOR-interacting protein-like isoform X1
ADP ribosylation factor GTPase activating protein 1, transcript variant X2
ADP ribosylation factor GTPase activating protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ADP ribosylation factor GTPase activating protein 1, transcript variant X6
ADP ribosylation factor GTPase activating protein 1, transcript variant X1
ADP ribosylation factor GTPase activating protein 1, transcript variant X3
ADP ribosylation factor GTPase activating protein 1, transcript variant X4
ADP ribosylation factor GTPase activating protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ADP-ribosylation factor GTPase-activating protein 1 isoform X2
ADP-ribosylation factor GTPase-activating protein 1 isoform X3
ADP-ribosylation factor GTPase-activating protein 1 isoform X1
ADP-ribosylation factor GTPase-activating protein 1 isoform X4
sodium/potassium transporting ATPase interacting 4, transcript variant X1
sodium/potassium transporting ATPase interacting 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium/potassium transporting ATPase interacting 4, transcript variant X2
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
baculoviral IAP repeat-containing protein 7
YTH N6-methyladenosine RNA binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
YTH domain-containing family protein 1 isoform X1
YTH N6-methyladenosine RNA binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
YTH domain-containing family protein 1 isoform X2
basic helix-loop-helix family member e23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
class E basic helix-loop-helix protein 23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
GID complex subunit 8 homolog, transcript variant X1
GID complex subunit 8 homolog, transcript variant X2
GID complex subunit 8 homolog, transcript variant X3
glucose-induced degradation protein 8 homolog
death inducer-obliterator 1, transcript variant X3
death inducer-obliterator 1, transcript variant X1
death inducer-obliterator 1, transcript variant X2
death inducer-obliterator 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
death inducer-obliterator 1, transcript variant X5
death inducer-obliterator 1, transcript variant X7
death inducer-obliterator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
opioid growth factor receptor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
opioid growth factor receptor, transcript variant X1
opioid growth factor receptor, transcript variant X3
opioid growth factor receptor, transcript variant X4
opioid growth factor receptor, transcript variant X2
opioid growth factor receptor isoform X2
opioid growth factor receptor isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
solute carrier organic anion transporter family member 4A1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier organic anion transporter family member 4A1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier organic anion transporter family member 4A1, transcript variant X2
solute carrier organic anion transporter family member 4A1, transcript variant X4
solute carrier organic anion transporter family member 4A1 isoform X1
solute carrier organic anion transporter family member 4A1 isoform X2
uncharacterized LOC115635003, transcript variant X2
uncharacterized LOC115635003, transcript variant X1
uncharacterized LOC115635003, transcript variant X3
GATA binding protein 5, transcript variant X1
GATA binding protein 5, transcript variant X2
Cdk5 and Abl enzyme substrate 2, transcript variant X2
Cdk5 and Abl enzyme substrate 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
oxysterol binding protein like 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
oxysterol binding protein like 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
oxysterol binding protein like 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
oxysterol binding protein like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
oxysterol binding protein like 2, transcript variant X3
oxysterol binding protein like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
oxysterol binding protein like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
oxysterol binding protein like 2, transcript variant X5
oxysterol binding protein like 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
oxysterol binding protein like 2, transcript variant X7
oxysterol-binding protein-related protein 2 isoform X1
oxysterol-binding protein-related protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitochondrial ribosome associated GTPase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
mitochondrial ribosome associated GTPase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitochondrial ribosome associated GTPase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial ribosome associated GTPase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mitochondrial ribosome-associated GTPase 2
SS18L1 subunit of BAF chromatin remodeling complex
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
LSM family member 14B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LSM family member 14B, transcript variant X3
LSM family member 14B, transcript variant X4
LSM family member 14B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
TATA-box binding protein associated factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
TATA-box binding protein associated factor 4, transcript variant X2
transcription initiation factor TFIID subunit 4 isoform X1
transcription initiation factor TFIID subunit 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: cadherin-like protein 26
family with sequence similarity 217 member B, transcript variant X4
family with sequence similarity 217 member B, transcript variant X2
family with sequence similarity 217 member B, transcript variant X1
family with sequence similarity 217 member B, transcript variant X3
family with sequence similarity 217 member B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 3D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
phosphatase and actin regulator 3, transcript variant X6
phosphatase and actin regulator 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphatase and actin regulator 3, transcript variant X2
phosphatase and actin regulator 3, transcript variant X1
phosphatase and actin regulator 3, transcript variant X7
phosphatase and actin regulator 3, transcript variant X4
phosphatase and actin regulator 3, transcript variant X3
phosphatase and actin regulator 3 isoform X6
phosphatase and actin regulator 3 isoform X5
phosphatase and actin regulator 3 isoform X2
phosphatase and actin regulator 3 isoform X1
phosphatase and actin regulator 3 isoform X4
phosphatase and actin regulator 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 831, transcript variant X2
zinc finger protein 831, transcript variant X3
zinc finger protein 831, transcript variant X1
androgen-induced gene 1 protein-like, transcript variant X1
androgen-induced gene 1 protein-like, transcript variant X2
androgen-induced gene 1 protein-like, transcript variant X3
androgen-induced gene 1 protein-like, transcript variant X4
androgen-induced gene 1 protein-like isoform X4
androgen-induced gene 1 protein-like isoform X3
androgen-induced gene 1 protein-like isoform X1
androgen-induced gene 1 protein-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ATP synthase subunit epsilon, mitochondrial
tubulin beta 1 class VI, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tubulin beta 1 class VI, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
negative elongation factor complex member C/D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
negative elongation factor complex member C/D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
negative elongation factor complex member C/D, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
negative elongation factor C/D isoform X3
negative elongation factor C/D isoform X2
negative elongation factor C/D isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GNAS complex locus, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
GNAS complex locus, transcript variant X3
GNAS complex locus, transcript variant X2
GNAS complex locus, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GNAS complex locus, transcript variant X4
guanine nucleotide-binding protein G(s) subunit alpha isoform X5
guanine nucleotide-binding protein G(s) subunit alpha isoforms short isoform X3
guanine nucleotide-binding protein G(s) subunit alpha isoforms short isoform X2
guanine nucleotide-binding protein G(s) subunit alpha isoforms short isoform X1
guanine nucleotide-binding protein G(s) subunit alpha isoform X4
piezo-type mechanosensitive ion channel component 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
aminopeptidase like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
aminopeptidase like 1, transcript variant X3
probable aminopeptidase NPEPL1 isoform X1
probable aminopeptidase NPEPL1 isoform X3
aminopeptidase like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable aminopeptidase NPEPL1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
APC down-regulated 1 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
APC down-regulated 1 like, transcript variant X1
VAMP associated protein B and C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
VAMP associated protein B and C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
vesicle-associated membrane protein-associated protein B/C isoform X2
vesicle-associated membrane protein-associated protein B/C isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain-containing protein 60
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein C20orf85 homolog
uncharacterized LOC115635095, transcript variant X2
uncharacterized LOC115635095, transcript variant X1
prostate transmembrane protein, androgen induced 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
prostate transmembrane protein, androgen induced 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
prostate transmembrane protein, androgen induced 1, transcript variant X3
prostate transmembrane protein, androgen induced 1, transcript variant X5
prostate transmembrane protein, androgen induced 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
phosphoenolpyruvate carboxykinase, cytosolic [GTP]
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: transcriptional repressor CTCFL
uncharacterized LOC115635048, transcript variant X2
uncharacterized LOC115635048, transcript variant X1
uncharacterized LOC115635048, transcript variant X5
uncharacterized LOC115635048, transcript variant X3
uncharacterized LOC115635048, transcript variant X4
uncharacterized LOC115635048, transcript variant X6
RNA binding motif protein 38, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
RNA binding motif protein 38, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC115634996, transcript variant X2
uncharacterized LOC115634996, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
SPO11 initiator of meiotic double stranded breaks, transcript variant X2
SPO11 initiator of meiotic double stranded breaks, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SPO11 initiator of meiotic double stranded breaks, transcript variant X4
SPO11 initiator of meiotic double stranded breaks, transcript variant X1
SPO11 initiator of meiotic double stranded breaks, transcript variant X3
meiotic recombination protein SPO11 isoform X4
meiotic recombination protein SPO11 isoform X3
meiotic recombination protein SPO11 isoform X1
meiotic recombination protein SPO11 isoform X2
bone morphogenetic protein 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bone morphogenetic protein 7, transcript variant X3
bone morphogenetic protein 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X1
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X2
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7-like
Cas scaffold protein family member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Cas scaffold protein family member 4, transcript variant X5
Cas scaffold protein family member 4, transcript variant X1
Cas scaffold protein family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Cas scaffold protein family member 4, transcript variant X2
cas scaffolding protein family member 4 isoform X4
cas scaffolding protein family member 4 isoform X3
cas scaffolding protein family member 4 isoform X1
cas scaffolding protein family member 4 isoform X2
cleavage stimulation factor subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
cleavage stimulation factor subunit 1, transcript variant X2
cleavage stimulation factor subunit 1 isoform X1
cleavage stimulation factor subunit 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
family with sequence similarity 210 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
family with sequence similarity 210 member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC115635054, transcript variant X3
uncharacterized LOC115635054, transcript variant X1
uncharacterized LOC115635054, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC115635286 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 22% coverage of the annotated genomic feature by RNAseq alignments
docking protein 5, transcript variant X3
docking protein 5, transcript variant X1
docking protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
docking protein 5, transcript variant X5
docking protein 5, transcript variant X4
uncharacterized LOC115634919, transcript variant X3
uncharacterized LOC115634919, transcript variant X2
uncharacterized LOC115634919, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X3
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X3
breast carcinoma amplified sequence 1, transcript variant X3
breast carcinoma amplified sequence 1, transcript variant X4
breast carcinoma amplified sequence 1, transcript variant X2
breast carcinoma amplified sequence 1, transcript variant X1
breast carcinoma-amplified sequence 1 isoform X1
breast carcinoma-amplified sequence 1 isoform X2
breast carcinoma-amplified sequence 1 isoform X4
breast carcinoma-amplified sequence 1 isoform X3
zinc finger protein 217, transcript variant X3
zinc finger protein 217, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein 217, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 217, transcript variant X6
zinc finger protein 217, transcript variant X5
zinc finger protein 217, transcript variant X4
ZFP64 zinc finger protein, transcript variant X7
ZFP64 zinc finger protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ZFP64 zinc finger protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ZFP64 zinc finger protein, transcript variant X8
ZFP64 zinc finger protein, transcript variant X3
ZFP64 zinc finger protein, transcript variant X1
ZFP64 zinc finger protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ZFP64 zinc finger protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
ATPase phospholipid transporting 9A (putative)
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable phospholipid-transporting ATPase IIA
nuclear factor of activated T cells 2, transcript variant X5
nuclear factor of activated T cells 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear factor of activated T cells 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear factor of activated T cells 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 2 isoform X1
nuclear factor of activated T-cells, cytoplasmic 2 isoform X2
nuclear factor of activated T-cells, cytoplasmic 2 isoform X3
nuclear factor of activated T cells 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 2 isoform X4
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X2
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X3
potassium voltage-gated channel modifier subfamily G member 1, transcript variant X1
potassium voltage-gated channel subfamily G member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
adenylyltransferase and sulfurtransferase MOCS3
dolichyl-phosphate mannosyltransferase subunit 1, catalytic
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
dolichol-phosphate mannosyltransferase subunit 1
activity dependent neuroprotector homeobox, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
activity dependent neuroprotector homeobox, transcript variant X4
activity dependent neuroprotector homeobox, transcript variant X8
activity dependent neuroprotector homeobox, transcript variant X1
activity dependent neuroprotector homeobox, transcript variant X6
activity dependent neuroprotector homeobox, transcript variant X2
activity dependent neuroprotector homeobox, transcript variant X7
activity dependent neuroprotector homeobox, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
activity-dependent neuroprotector homeobox protein isoform X1
activity-dependent neuroprotector homeobox protein isoform X2
activity dependent neuroprotector homeobox, transcript variant X9
activity-dependent neuroprotector homeobox protein isoform X3
breast carcinoma amplified sequence 4, transcript variant X2
breast carcinoma amplified sequence 4, transcript variant X3
breast carcinoma amplified sequence 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
breast carcinoma-amplified sequence 4 isoform X1
breast carcinoma-amplified sequence 4 isoform X2
par-6 family cell polarity regulator beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RIPOR family member 3, transcript variant X1
RIPOR family member 3, transcript variant X2
protein tyrosine phosphatase non-receptor type 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 1, transcript variant X3
tyrosine-protein phosphatase non-receptor type 1 isoform X1
tyrosine-protein phosphatase non-receptor type 1 isoform X2
tyrosine-protein phosphatase non-receptor type 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin-conjugating enzyme E2 variant 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 variant 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 variant 1 isoform X1
ubiquitin-conjugating enzyme E2 variant 1 isoform X2
snail family transcriptional repressor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
spermatogenesis associated 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
spermatogenesis associated 2, transcript variant X3
spermatogenesis associated 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 9 member A8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
solute carrier family 9 member A8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: prostacyclin synthase
potassium voltage-gated channel subfamily B member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel subfamily B member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily B member 1
somatomedin-B and thrombospondin type-1 domain-containing protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00581
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
staufen double-stranded RNA binding protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
staufen double-stranded RNA binding protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
staufen double-stranded RNA binding protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
staufen double-stranded RNA binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
staufen double-stranded RNA binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
staufen double-stranded RNA binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
staufen double-stranded RNA binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
double-stranded RNA-binding protein Staufen homolog 1 isoform X4
double-stranded RNA-binding protein Staufen homolog 1 isoform X3
double-stranded RNA-binding protein Staufen homolog 1 isoform X2
double-stranded RNA-binding protein Staufen homolog 1 isoform X5
double-stranded RNA-binding protein Staufen homolog 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
brefeldin A-inhibited guanine nucleotide-exchange protein 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: brefeldin A-inhibited guanine nucleotide-exchange protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
brefeldin A-inhibited guanine nucleotide-exchange protein 2, transcript variant X1
brefeldin A-inhibited guanine nucleotide-exchange protein 2, transcript variant X2
brefeldin A-inhibited guanine nucleotide-exchange protein 2 isoform X1
brefeldin A-inhibited guanine nucleotide-exchange protein 2 isoform X2
brefeldin A-inhibited guanine nucleotide-exchange protein 2, transcript variant X3
brefeldin A-inhibited guanine nucleotide-exchange protein 2 isoform X3
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X1
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X1
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X2
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X3
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1, transcript variant X4
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
extracellular sulfatase Sulf-2 isoform X1
extracellular sulfatase Sulf-2 isoform X2
nuclear receptor coactivator 3, transcript variant X2
nuclear receptor coactivator 3, transcript variant X1
nuclear receptor coactivator 3 isoform X2
nuclear receptor coactivator 3 isoform X1
translocating chain-associated membrane protein 1-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
translocating chain-associated membrane protein 1-like 1, transcript variant X3
translocating chain-associated membrane protein 1-like 1, transcript variant X2
translocating chain-associated membrane protein 1-like 1 isoform X1
translocating chain-associated membrane protein 1-like isoform X2
translocating chain-associated membrane protein 1-like 1 isoform X3
zinc finger MYND-type containing 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein kinase C-binding protein 1 isoform X1
protein kinase C-binding protein 1 isoform X4
protein kinase C-binding protein 1 isoform X2
zinc finger MYND-type containing 8, transcript variant X6
zinc finger MYND-type containing 8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger MYND-type containing 8, transcript variant X3
protein kinase C-binding protein 1 isoform X3
zinc finger MYND-type containing 8, transcript variant X7
protein kinase C-binding protein 1 isoform X5
EYA transcriptional coactivator and phosphatase 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
EYA transcriptional coactivator and phosphatase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EYA transcriptional coactivator and phosphatase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
EYA transcriptional coactivator and phosphatase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
EYA transcriptional coactivator and phosphatase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EYA transcriptional coactivator and phosphatase 2, transcript variant X3
EYA transcriptional coactivator and phosphatase 2, transcript variant X7
EYA transcriptional coactivator and phosphatase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
osteoclast stimulatory transmembrane protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: osteoclast stimulatory transmembrane protein
thyrotropin-releasing hormone receptor-like, transcript variant X2
thyrotropin-releasing hormone receptor-like, transcript variant X1
thyrotropin-releasing hormone receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
oxidative stress responsive serine rich 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
oxidative stress responsive serine rich 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
oxidative stress-responsive serine-rich protein 1 isoform X1
oxidative stress-responsive serine-rich protein 1 isoform X2
oxidative stress-responsive serine-rich protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
oxidative stress-responsive serine-rich protein 1-like isoform X1
oxidative stress-responsive serine-rich protein 1-like, transcript variant X5
oxidative stress-responsive serine-rich protein 1-like, transcript variant X4
oxidative stress-responsive serine-rich protein 1-like, transcript variant X2
oxidative stress-responsive serine-rich protein 1-like isoform X2
oxidative stress-responsive serine-rich protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
oxidative stress-responsive serine-rich protein 1-like isoform X3
oxidative stress-responsive serine-rich protein 1-like isoform X4
ganglioside induced differentiation associated protein 1 like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ganglioside-induced differentiation-associated protein 1-like 1
fat storage inducing transmembrane protein 2, transcript variant X3
fat storage inducing transmembrane protein 2, transcript variant X2
fat storage-inducing transmembrane protein 2 isoform X2
fat storage inducing transmembrane protein 2, transcript variant X1
fat storage-inducing transmembrane protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hepatocyte nuclear factor 4 alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
hepatocyte nuclear factor 4-alpha isoform X1
hepatocyte nuclear factor 4 alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
hepatocyte nuclear factor 4-alpha isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
cAMP-dependent protein kinase inhibitor gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cAMP-dependent protein kinase inhibitor gamma, transcript variant X2
cAMP-dependent protein kinase inhibitor gamma isoform X1
cAMP-dependent protein kinase inhibitor gamma isoform X2
adenosine deaminase-like, transcript variant X2
adenosine deaminase-like, transcript variant X1
WNT1-inducible-signaling pathway protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
LOW QUALITY PROTEIN: P2Y purinoceptor 1-like
potassium two pore domain channel subfamily K member 15
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LOW QUALITY PROTEIN: potassium channel subfamily K member 15
regulating synaptic membrane exocytosis 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulating synaptic membrane exocytosis protein 4
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
LOW QUALITY PROTEIN: 14-3-3 protein beta/alpha
poly(A) binding protein cytoplasmic 1 like, transcript variant X1
poly(A) binding protein cytoplasmic 1 like, transcript variant X2
poly(A) binding protein cytoplasmic 1 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
poly(A) binding protein cytoplasmic 1 like, transcript variant X4
poly(A) binding protein cytoplasmic 1 like, transcript variant X5
polyadenylate-binding protein 1-like isoform X1
polyadenylate-binding protein 1-like isoform X2
polyadenylate-binding protein 1-like isoform X3
polyadenylate-binding protein 1-like isoform X4
polyadenylate-binding protein 1-like isoform X5
translocase of outer mitochondrial membrane 34
mitochondrial import receptor subunit TOM34
serine/threonine kinase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
serine/threonine kinase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
serine/threonine kinase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein kinase 4 isoform X1
serine/threonine-protein kinase 4 isoform X2
serine/threonine-protein kinase 4 isoform X3
potassium voltage-gated channel modifier subfamily S member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily S member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
recombination signal binding protein for immunoglobulin kappa J region like, transcript variant X1
recombination signal binding protein for immunoglobulin kappa J region like, transcript variant X3
recombination signal binding protein for immunoglobulin kappa J region like, transcript variant X2
recombining binding protein suppressor of hairless-like protein isoform X1
recombining binding protein suppressor of hairless-like protein isoform X3
recombining binding protein suppressor of hairless-like protein isoform X2
SYS1 golgi trafficking protein, transcript variant X2
SYS1 golgi trafficking protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SYS1 golgi trafficking protein, transcript variant X7
SYS1 golgi trafficking protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SYS1 golgi trafficking protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
SYS1 golgi trafficking protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
SYS1 golgi trafficking protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dysbindin domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dysbindin domain-containing protein 2 isoform X2
dysbindin domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dysbindin domain-containing protein 2 isoform X1
dysbindin domain containing 2, transcript variant X3
dysbindin domain-containing protein 2 isoform X3
phosphatidylinositol glycan anchor biosynthesis class T
BLCAP apoptosis inducing factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
BLCAP apoptosis inducing factor, transcript variant X3
BLCAP apoptosis inducing factor, transcript variant X2
BLCAP apoptosis inducing factor, transcript variant X4
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X1
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant X2
proto-oncogene tyrosine-protein kinase Src isoform X3
proto-oncogene tyrosine-protein kinase Src isoform X2
proto-oncogene tyrosine-protein kinase Src isoform X1
mannosidase beta like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mannosidase beta like, transcript variant X1
growth hormone releasing hormone, transcript variant X1
growth hormone releasing hormone, transcript variant X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidate phosphatase LPIN3 isoform X2
phosphatidate phosphatase LPIN3 isoform X1
phospholipase C gamma 1, transcript variant X4
phospholipase C gamma 1, transcript variant X2
phospholipase C gamma 1, transcript variant X3
phospholipase C gamma 1, transcript variant X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
DNA topoisomerase I, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
DNA topoisomerase I, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
DEAH-box helicase 35, transcript variant X2
DEAH-box helicase 35, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable ATP-dependent RNA helicase DHX35 isoform X2
probable ATP-dependent RNA helicase DHX35 isoform X1
family with sequence similarity 83 member D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 16B, transcript variant X2
protein phosphatase 1 regulatory subunit 16B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 16B
Rho GTPase activating protein 40, transcript variant X8
Rho GTPase activating protein 40, transcript variant X1
Rho GTPase activating protein 40, transcript variant X4
Rho GTPase activating protein 40, transcript variant X3
Rho GTPase activating protein 40, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Rho GTPase activating protein 40, transcript variant X2
Rho GTPase activating protein 40, transcript variant X6
rho GTPase-activating protein 40 isoform X1
rho GTPase-activating protein 40 isoform X4
rho GTPase-activating protein 40 isoform X3
rho GTPase-activating protein 40 isoform X5
rho GTPase-activating protein 40 isoform X2
rho GTPase-activating protein 40 isoform X6
Rho GTPase activating protein 40, transcript variant X7
rho GTPase-activating protein 40 isoform X7
solute carrier family 32 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 32 member 1, transcript variant X3
solute carrier family 32 member 1, transcript variant X2
vesicular inhibitory amino acid transporter
protein tyrosine phosphatase receptor type T, transcript variant X1
protein tyrosine phosphatase receptor type T, transcript variant X3
protein tyrosine phosphatase receptor type T, transcript variant X5
protein tyrosine phosphatase receptor type T, transcript variant X6
protein tyrosine phosphatase receptor type T, transcript variant X2
protein tyrosine phosphatase receptor type T, transcript variant X4
receptor-type tyrosine-protein phosphatase T isoform X1
receptor-type tyrosine-protein phosphatase T isoform X3
receptor-type tyrosine-protein phosphatase T isoform X5
receptor-type tyrosine-protein phosphatase T isoform X6
receptor-type tyrosine-protein phosphatase T isoform X2
receptor-type tyrosine-protein phosphatase T isoform X4
MYB proto-oncogene like 2, transcript variant X2
MYB proto-oncogene like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MYB proto-oncogene like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
intraflagellar transport 52, transcript variant X1
intraflagellar transport 52, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
intraflagellar transport 52, transcript variant X3
intraflagellar transport 52, transcript variant X4
intraflagellar transport protein 52 homolog isoform X1
intraflagellar transport protein 52 homolog isoform X2
intraflagellar transport protein 52 homolog isoform X3
intraflagellar transport protein 52 homolog isoform X4
serum/glucocorticoid regulated kinase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serum/glucocorticoid regulated kinase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serum/glucocorticoid regulated kinase 2, transcript variant X3
serum/glucocorticoid regulated kinase 2, transcript variant X1
serum/glucocorticoid regulated kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase Sgk2 isoform X3
serine/threonine-protein kinase Sgk2 isoform X1
serine/threonine-protein kinase Sgk2 isoform X2
serine/threonine-protein kinase Sgk2 isoform X4
L3MBTL histone methyl-lysine binding protein 1, transcript variant X2
L3MBTL histone methyl-lysine binding protein 1, transcript variant X3
L3MBTL histone methyl-lysine binding protein 1, transcript variant X1
lethal(3)malignant brain tumor-like protein 1 isoform X2
lethal(3)malignant brain tumor-like protein 1 isoform X1
serine and arginine rich splicing factor 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X4
erythrocyte membrane protein band 4.1 like 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X8
erythrocyte membrane protein band 4.1 like 1, transcript variant X11
erythrocyte membrane protein band 4.1 like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 1, transcript variant X12
erythrocyte membrane protein band 4.1 like 1, transcript variant X9
erythrocyte membrane protein band 4.1 like 1, transcript variant X2
erythrocyte membrane protein band 4.1 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
AAR2 splicing factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
AAR2 splicing factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
AAR2 splicing factor, transcript variant X5
AAR2 splicing factor, transcript variant X8
AAR2 splicing factor, transcript variant X3
AAR2 splicing factor, transcript variant X7
AAR2 splicing factor, transcript variant X9
AAR2 splicing factor, transcript variant X4
AAR2 splicing factor, transcript variant X1
DLG associated protein 4, transcript variant X4
DLG associated protein 4, transcript variant X2
DLG associated protein 4, transcript variant X1
DLG associated protein 4, transcript variant X3
disks large-associated protein 4 isoform X1
disks large-associated protein 4 isoform X2
disks large-associated protein 4 isoform X3
DLG associated protein 4, transcript variant X5
disks large-associated protein 4 isoform X4
TGFB induced factor homeobox 2, transcript variant X3
TGFB induced factor homeobox 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TGFB induced factor homeobox 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
gamma-glutamyltransferase 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
gamma-glutamyltransferase 7, transcript variant X1
gamma-glutamyltransferase 7, transcript variant X2
nuclear receptor coactivator 6, transcript variant X1
nuclear receptor coactivator 6, transcript variant X2
nuclear receptor coactivator 6, transcript variant X3
nuclear receptor coactivator 6 isoform X1
nuclear receptor coactivator 6 isoform X2
nuclear receptor coactivator 6 isoform X3
tumor protein p53 inducible nuclear protein 2, transcript variant X3
tumor protein p53 inducible nuclear protein 2, transcript variant X1
tumor protein p53 inducible nuclear protein 2, transcript variant X2
tumor protein p53-inducible nuclear protein 2 isoform X2
tumor protein p53-inducible nuclear protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
phosphatidylinositol glycan anchor biosynthesis class U
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class U protein
microtubule associated protein 1 light chain 3 alpha, transcript variant X2
microtubule associated protein 1 light chain 3 alpha, transcript variant X1
microtubule-associated proteins 1A/1B light chain 3A isoform X2
microtubule-associated proteins 1A/1B light chain 3A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
itchy E3 ubiquitin protein ligase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
itchy E3 ubiquitin protein ligase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
itchy E3 ubiquitin protein ligase, transcript variant X3
E3 ubiquitin-protein ligase Itchy homolog isoform X1
E3 ubiquitin-protein ligase Itchy homolog isoform X2
E3 ubiquitin-protein ligase Itchy homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 2 subunit beta, transcript variant X1
eukaryotic translation initiation factor 2 subunit 2 isoform X1
eukaryotic translation initiation factor 2 subunit beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
eukaryotic translation initiation factor 2 subunit 2 isoform X2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X1
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X3
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X5
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X4
uncharacterized LOC115635125, transcript variant X8
uncharacterized LOC115635125, transcript variant X3
uncharacterized LOC115635125, transcript variant X7
uncharacterized LOC115635125, transcript variant X4
uncharacterized LOC115635125, transcript variant X2
uncharacterized LOC115635125, transcript variant X5
uncharacterized LOC115635125, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC115635125, transcript variant X6
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC115634854, transcript variant X1
uncharacterized LOC115634854, transcript variant X2
uncharacterized LOC115634854, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 341, transcript variant X1
zinc finger protein 341, transcript variant X2
peroxisomal membrane protein 4, transcript variant X2
peroxisomal membrane protein 4 isoform X2
peroxisomal membrane protein 4, transcript variant X1
peroxisomal membrane protein 4 isoform X1
E2F transcription factor 1, transcript variant X2
E2F transcription factor 1, transcript variant X3
E2F transcription factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
N-terminal EF-hand calcium binding protein 3
N-terminal EF-hand calcium-binding protein 3
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X5
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CBFA2/RUNX1 partner transcriptional co-repressor 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC115634943, transcript variant X1
uncharacterized LOC115634943, transcript variant X2
syntrophin alpha 1, transcript variant X1
syntrophin alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X1
TOX high mobility group box family member 2, transcript variant X4
TOX high mobility group box family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X2
TOX high mobility group box family member 2 isoform X4
TOX high mobility group box family member 2 isoform X3
TOX high mobility group box family member 2 isoform X1
TOX high mobility group box family member 2 isoform X2
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X1
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X2
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X1
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X2
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X3
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X3
transient receptor potential cation channel subfamily C member 4 associated protein
short transient receptor potential channel 4-associated protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutathione synthetase, transcript variant X1
glutathione synthetase, transcript variant X4
glutathione synthetase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glutathione synthetase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
acyl-CoA synthetase short chain family member 2, transcript variant X2
acyl-CoA synthetase short chain family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
acyl-CoA synthetase short chain family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
acetyl-coenzyme A synthetase, cytoplasmic isoform X2
acetyl-coenzyme A synthetase, cytoplasmic isoform X1
acetyl-coenzyme A synthetase, cytoplasmic isoform X3
suppressor of glucose, autophagy associated 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X4
suppressor of glucose, autophagy associated 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
deoxynucleoside triphosphate triphosphohydrolase SAMHD1
RB transcriptional corepressor like 1, transcript variant X2
RB transcriptional corepressor like 1, transcript variant X1
RB transcriptional corepressor like 1, transcript variant X5
RB transcriptional corepressor like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RB transcriptional corepressor like 1, transcript variant X4
RB transcriptional corepressor like 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
RB transcriptional corepressor like 1, transcript variant X7
retinoblastoma-like protein 1 isoform X2
retinoblastoma-like protein 1 isoform X1
retinoblastoma-like protein 1 isoform X3
retinoblastoma-like protein 1 isoform X4
retinoblastoma-like protein 1 isoform X7
retinoblastoma-like protein 1 isoform X6
RB transcriptional corepressor like 1, transcript variant X6
retinoblastoma-like protein 1 isoform X5
chromodomain helicase DNA binding protein 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X5
chromodomain helicase DNA binding protein 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
chromodomain helicase DNA binding protein 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X9
chromodomain-helicase-DNA-binding protein 6 isoform X1
chromodomain-helicase-DNA-binding protein 6 isoform X3
chromodomain-helicase-DNA-binding protein 6 isoform X2
chromodomain-helicase-DNA-binding protein 6 isoform X4
chromodomain-helicase-DNA-binding protein 6 isoform X5
Ral GTPase activating protein non-catalytic beta subunit
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ral GTPase-activating protein subunit beta
NDRG family member 3, transcript variant X3
NDRG family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NDRG family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NDRG family member 3, transcript variant X4
NDRG family member 3, transcript variant X5
Src like adaptor 2, transcript variant X2
Src like adaptor 2, transcript variant X1
PHD finger protein 20, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PHD finger protein 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
PHD finger protein 20, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
PHD finger protein 20, transcript variant X1
PHD finger protein 20, transcript variant X4
PHD finger protein 20, transcript variant X6
PHD finger protein 20, transcript variant X3
PHD finger protein 20, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PHD finger protein 20, transcript variant X2
PHD finger protein 20, transcript variant X10
RNA binding motif protein 39, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
RNA binding motif protein 39, transcript variant X3
RNA binding motif protein 39, transcript variant X1
NFS1 cysteine desulfurase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cysteine desulfurase, mitochondrial isoform X1
NFS1 cysteine desulfurase, transcript variant X2
cysteine desulfurase, mitochondrial isoform X2
NFS1 cysteine desulfurase, transcript variant X3
cysteine desulfurase, mitochondrial isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
fer-1-like protein 4, transcript variant X1
fer-1-like protein 4, transcript variant X2
fer-1-like protein 4, transcript variant X3
matrix metallopeptidase 24, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
matrix metallopeptidase 24, transcript variant X2
matrix metallopeptidase 24, transcript variant X3
eukaryotic translation initiation factor 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC115635084, transcript variant X2
family with sequence similarity 83 member C
uncharacterized LOC115635084, transcript variant X3
uncharacterized LOC115635084, transcript variant X1
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X4
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X2
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X1
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X3
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2-like
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like
ERGIC and golgi 3, transcript variant X2
ERGIC and golgi 3, transcript variant X1
ERGIC and golgi 3, transcript variant X3
endoplasmic reticulum-Golgi intermediate compartment protein 3 isoform X2
endoplasmic reticulum-Golgi intermediate compartment protein 3 isoform X1
endoplasmic reticulum-Golgi intermediate compartment protein 3 isoform X3
centrosomal protein 250, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
centrosomal protein 250, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
centrosomal protein 250, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
centrosomal protein 250, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
centrosomal protein 250, transcript variant X5
centrosomal protein 250, transcript variant X8
centrosomal protein 250, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
centrosomal protein 250, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
centrosomal protein 250, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
centrosomal protein 250, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
centrosomal protein 250, transcript variant X7
centrosomal protein 250, transcript variant X1
centrosome-associated protein CEP250 isoform X5
centrosome-associated protein CEP250 isoform X8
centrosome-associated protein CEP250 isoform X4
centrosome-associated protein CEP250 isoform X7
centrosome-associated protein CEP250 isoform X3
centrosome-associated protein CEP250 isoform X10
centrosome-associated protein CEP250 isoform X11
centrosome-associated protein CEP250 isoform X9
centrosome-associated protein CEP250 isoform X6
centrosome-associated protein CEP250 isoform X1
centrosome-associated protein CEP250 isoform X2
small nuclear RNA activating complex polypeptide 2, transcript variant X4
small nuclear RNA activating complex polypeptide 2, transcript variant X3
small nuclear RNA activating complex polypeptide 2, transcript variant X2
small nuclear RNA activating complex polypeptide 2, transcript variant X1
snRNA-activating protein complex subunit 2 isoform X1
snRNA-activating protein complex subunit 2 isoform X2
Rho guanine nucleotide exchange factor 40
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 2 homolog, transcript variant X6
zinc finger protein 2 homolog, transcript variant X5
zinc finger protein 2 homolog, transcript variant X7
zinc finger protein 2 homolog, transcript variant X4
zinc finger protein 2 homolog, transcript variant X3
zinc finger protein 2 homolog, transcript variant X9
zinc finger protein 2 homolog, transcript variant X8
zinc finger protein 2 homolog, transcript variant X1
zinc finger protein 2 homolog, transcript variant X2
zinc finger protein 2 homolog isoform X1
zinc finger protein 2 homolog isoform X2
NDRG family member 2, transcript variant X3
NDRG family member 2, transcript variant X1
NDRG family member 2, transcript variant X2
von Willebrand factor A domain-containing protein 5A-like, transcript variant X10
von Willebrand factor A domain-containing protein 5A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
von Willebrand factor A domain-containing protein 5A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 5A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 5A-like, transcript variant X5
von Willebrand factor A domain-containing protein 5A-like isoform X2
von Willebrand factor A domain-containing protein 5A-like isoform X1
von Willebrand factor A domain-containing protein 5A-like isoform X5
von Willebrand factor A domain-containing protein 5A-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 5A-like, transcript variant X8
von Willebrand factor A domain-containing protein 5A-like isoform X7
von Willebrand factor A domain-containing protein 5A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 5A-like isoform X3
von Willebrand factor A domain-containing protein 5A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 5A-like, transcript variant X7
von Willebrand factor A domain-containing protein 5A-like isoform X4
von Willebrand factor A domain-containing protein 5A-like, transcript variant X6
von Willebrand factor A domain-containing protein 5A-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins